Clinical Trial Update: Identifying Biomarkers for Early Detection of Cancer in Patients With Cervical Dysplasia or Carcinoma in Situ of the Cervix

View source ↗

Summary

A completed clinical study identifying biomarkers for early detection of cervical cancer in patients with cervical dysplasia or carcinoma in situ of the cervix.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Dysplasia

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Cervical Cancer, Precancerous Condition | Status: COMPLETED